Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models-Reference-Cited by-同舟云学术

Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models

Published:2016-05-10 Issue:10 Volume:18 Page:1390-1401
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:NEUONC

Author:

Yagiz Kader,Huang Tiffany T.,Lopez Espinoza Fernando,Mendoza Daniel,Ibañez Carlos E.,Gruber Harry E.,Jolly Douglas J.,Robbins Joan M.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/18/10/1390/17430879/now089.pdf

Reference36 articles.

1. The future of high-grade glioma: where we are and where are we going;Le Rhun;Surg Neurol Intern,2015

2. Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression

3. Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector

4. Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model

5. Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma model;Huang;Hum Gene Ther,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing antifungal drugs for cancer therapy;Journal of Advanced Research;2022-09

2. Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance;Cancer Science;2021-10-02

3. Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas;Molecules;2021-02-22

4. Cell and gene therapies—Emerging technologies and drug delivery systems for treating brain cancer;Advanced Drug Delivery Systems in the Management of Cancer;2021

5. The Oncolytic Virus in Cancer Diagnosis and Treatment;Frontiers in Oncology;2020-09-09